Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
Select Region
Selecting your primary region ensures you get the stories that matter to you first.
SAN ANTONIO – An experimental drug is showing promise against a hard-to-treat form of breast cancer. It’s the first big result from a novel way to test drugs that quickly separates winners from duds.
Doctors say the results on veliparib (veh-LIP-uh-rib) suggest it deserves further testing in a big study aimed at winning federal approval.
The drug was tested on small groups of women who were quickly given surgery to see its effect on their tumors. Each person’s results helped inform how the next women in the study were treated.
Researchers say this learn-as-you-go approach should get promising treatments to market faster and at a lower cost.
The study was discussed Friday at a conference in San Antonio.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.